共 245 条
[1]
Bertolli J(1996)Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire J Infect Dis. 174 722-6
[2]
St Louis ME(1995)Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group Am J Epidemiol. 12 1330-7
[3]
Simonds RJ(1996)Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load JAMA 275 599-605
[4]
Rouzioux C(1999)Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group N Engl J Med. 341 394-402
[5]
Costagliola D(2001)Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections J Infect Dis. 183 206-12
[6]
Burgard M(1999)Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team N Engl J Med. 341 385-93
[7]
Dickover RE(1999)Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one AIDS 13 1377-85
[8]
Garratty EM(1996)Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group N Engl J Med. 335 1621-9
[9]
Herman SA(2000)Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group J Infect Dis 181 99-106
[10]
Garcia PM(1998)Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort JAMA 280 55-60